Curaleaf Holdings, Inc. (CURLF) Reports Q3 Loss, Beats Revenue Estimates

Curaleaf Holdings (CURLF) reported a Q3 loss of $0.14 per share, beating estimates. Revenue was $352.65M, up 10.7% YoY. The company has beaten EPS and revenue estimates for four consecutive quarters. Shares are up 21.2% YTD. The stock has a Zacks Rank #3 (Hold).

Original reporting
Published Nov 3, 2026, 11:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 1:57 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CURLF
Bullish
high confidence
Mentioned
$CURLF
Relevance
8/10
AlphAI data visualization · based on finance.yahoo.com
Decision brief

The 30-second read

$CURLFBullishHigh
01

Why it matters

The earnings surprise could trigger short‑term buying pressure, but the modest scale limits the move.

02

Market read

Earnings beat provides a fresh catalyst for the stock and may influence peer valuations in the cannabis sector.

03

What to watch

Future guidance is flat and the market may focus on cash flow and regulatory risks.

Relevance 8/10Novelty 8/10Timing: after‑hours release

Background

Curaleaf Holdings reported its Q3 2026 results, beating consensus on both earnings per share and revenue.

Company-level read

Ticker impact

$CURLFBullishHigh confidence
Context

Q3 earnings beat revenue and loss expectations, reporting a loss of $0.14 per share versus a $0.16 consensus loss and revenue of $352.65 M versus $346.5 M estimate.

Expected impact

potential modest upside as the market prices in the earnings beat

Evidence & confidence

The surprise earnings and revenue beat provide fresh, material information that can move the share price in the short term.

Market effects

May boost sentiment for the broader cannabis sector as a peer shows earnings resilience.

Limited to U.S. cannabis stocks; no broader regional effect.

Low global relevance beyond sector.

Counterpoint

Despite the beat, the company remains loss‑making; investors may stay cautious.

Key entities

  • Curaleaf Holdings, Inc.

    U.S. cannabis operator reporting Q3 earnings.

Related articles

$CURLFMedAI 8/10

Curaleaf Holdings Inc (CURLF) (Q3 2026) Earnings Call Highlights: Record $353 Million

Curaleaf reported Q3 2026 revenue of $353M, up 11% YoY, with adjusted gross margin down 190bps to 49%. German market price compression and operational disruptions impacted margins. Net loss was $37M. Q4 revenue guidance suggests 1-2% sequential growth. CEO Boris Jordan discussed potential bid improvements for Aurora and regulatory challenges. Capital expenditures are expected to be $80M, limiting free cash flow.

Med

Curaleaf Q3 Revenue Hits Record $352.7 Million as Margins Contract

Curaleaf Holdings reported Q3 2026 revenue of $352.7M, up 10.9% YoY, but margins contracted. Net loss was $37.4M. Domestic revenue rose 8% to $294M, while international revenue grew 28% to $58.7M. Adjusted EBITDA increased to $77.6M. The company aims for $150M in full-year operating cash flow, with $104.9M cash and $636.9M debt at Q3 end. It also pursued Aurora Cannabis acquisition.